Opsoclonus myoclonus ataxia syndrome, ovarian teratoma and anti-NMDAR antibody: an ‘unresolved’ mystery
Background Opsoclonus–myoclonus–ataxia syndrome (OMAS) is characterised by the combination of opsoclonus and arrhythmic action myoclonus with axial ataxia and dysarthria. In adults, a majority are paraneoplastic secondary to solid organ tumours and could harbour antibodies against intracellular epit...
Saved in:
| Main Authors: | Vivek Mathew, Sanjith Aaron, Ajith Sivadasan, Sharon Milton, Angel T Miraclin, Arun Mathai Mani, Aditya Nair, Munagapati Christina, Abigail Ruth Gojer, John A Jude Prakash, Rohit N Benjamin, Appaswamy Thirumal Prabhakar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-06-01
|
| Series: | BMJ Neurology Open |
| Online Access: | https://neurologyopen.bmj.com/content/5/1/e000414.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opsoclonus-myoclonus syndrome in the course of teratoma: a case report
by: Mateusz Szczupak, et al.
Published: (2025-01-01) -
Opsoclonus-Myoclonus Outcome
by: J Gordon Millichap
Published: (1995-08-01) -
A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome
by: Adalet Altunsoy, et al.
Published: (2024-02-01) -
Outcome of Opsoclonus-Myoclonus Syndrome
by: J Gordon Millichap
Published: (2011-09-01) -
Pyridoxal phosphate binding protein (PLPBP) deficiency mimicking opsoclonus‐myoclonus‐ataxia syndrome
by: Mrinmayee Takle, et al.
Published: (2025-03-01)